Nukkleus eyes acquisitions in air defense sector
NEW YORK - Nukkleus Inc. (NASDAQ: NUKK), a $53.37 million market cap company whose stock has surged over 1,000% in the past six months according to InvestingPro data, has announced a strategic ...
Nukkleus sees opportunities in Air Defense, partners with Translink
Nukkleus (NUKK) has partnered with Translink Corporate Finance to identify acquisition opportunities in the air defense ...
Nukkleus up 11% afterhours at $28.47 on Translink pact
EST Nukkleus (NUKK) up 11% afterhours at $28.47 on Translink pactInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to ...
Le Lézard13d
AN2 Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, ...
Nukkleus Sees Accelerating Opportunities in Air Defense Thanks to Trump Executive Order to Develop U.S. 'Iron Dome'
Nukkleus Inc. (NASDAQ: NUKK) has partnered with Translink Corporate Finance to identify acquisition opportunities in the air defense sector, leveraging Translink's extensive expertise in mergers and ...
Investing18d
Nukkleus appoints retired Brigadier General as advisor
NEW YORK - Nukkleus Inc. (NASDAQ: NUKK), a Nasdaq-listed company specializing in the acquisition of high-potential businesses, announced the strategic appointment of Brigadier General (Ret.) Mark ...
Le Lézard18d
Nukkleus Appoints Brigadier General (Ret.) Mark Beesley as Strategic Advisor for Defense Acquisitions
Nukkleus Inc. is proud to announce the appointment of Brigadier General (Ret.) Mark Beesley as Strategic Advisor to the Board, focusing on defense sector acquisitions. This appointment follows the ...